Tyers Asset Management’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$396K Sell
5,292
-1,540
-23% -$131K 0.01% 536
2019
Q2
$551K Buy
6,832
+448
+7% +$31.5K 0.02% 457
2019
Q1
$427K Buy
6,384
+1,092
+21% +$82.7K 0.01% 508
2018
Q4
$394K Hold
5,292
0.02% 477
2018
Q3
$487K Buy
5,292
+1,148
+28% +$109K 0.02% 487
2018
Q2
$408K Hold
4,144
0.01% 492
2018
Q1
$462K Hold
4,144
0.02% 443
2017
Q4
$426K Buy
4,144
+728
+21% +$72.5K 0.01% 470
2017
Q3
$322K Buy
3,416
+476
+16% +$37.6K 0.01% 514
2017
Q2
$229K Buy
2,940
+1,232
+72% +$92.5K 0.01% 576
2017
Q1
$137K Sell
1,708
-56
-3% -$4.45K 0.01% 601
2016
Q4
$139K Buy
+1,764
New +$137K 0.01% 566

Other funds holding CMD

Tyers Asset Management's CMD Position: Q3 2019 in Review

Tyers Asset Management reduced its Cantel Medical Corporation (CMD) stake by 23% in Q3 2019, selling an estimated $131K and leaving 5,292 shares worth $396K. The position accounts for 0.01% of the portfolio, ranked #536.

Tyers Asset Management first reported a position in CMD in Q4 2016 and has held it in 12 quarters since. The position peaked at $551K in Q2 2019. 244 funds tracked by Wall St. Rank hold CMD as of Q3 2019.

  • Tyers Asset Management held 5,292 shares of Cantel Medical Corporation worth $396K as of Q3 2019.
  • Tyers Asset Management sold 1,540 Cantel Medical Corporation shares in Q3 2019, an estimated $131K.
  • Cantel Medical Corporation made up 0.01% of Tyers Asset Management's portfolio in Q3 2019, its #536 holding.
  • Tyers Asset Management first reported a position in Cantel Medical Corporation in Q4 2016 and has held it in 12 quarters since.
  • Tyers Asset Management's Cantel Medical Corporation position peaked at $551K in Q2 2019.
  • 244 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2019.

Based on Tyers Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.